Tenon Medical, Inc. Equity, Fair Value Disclosure
Tenon Medical, Inc. (TNON) had Equity, Fair Value Disclosure of $992 as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:EquityFairValueDisclosure · last filed 2024-11-14
- 2024-09-30: Equity, Fair Value Disclosure $992.00.
| Period end | Equity, Fair Value Disclosure |
|---|---|
| 2024-09-30 | $992.00 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |